CDC Chief Backs Measles Vaccine as Kennedy’s Agenda Falters

The CDC is navigating a period of unusual internal friction, as Acting Director Jay Bhattacharya publicly acknowledged “scientific” disagreements with Health and Human Services Secretary Robert F. Kennedy Jr. The revelation, made during a meeting with agency staff on Wednesday, signals a potential shift toward more conventional public health messaging, even as the administration struggles to find a permanent leader for the nation’s top public health agency.

A Return to Baseline?

Bhattacharya’s strong endorsement of the measles vaccine – stating it is “vital that every kid in this country get the measles vaccine” – went further than Kennedy’s previous, more tepid support. This stance aligns with decades of CDC guidance and represents a clear departure from some of the more controversial positions associated with the “Craft America Healthy Again” (MAHA) movement championed by Kennedy. The acting director also urged staff to “remove politics” from their work and focus on established scientific principles, a message that, while echoing Kennedy’s own slogans, also seemed to acknowledge the limitations of his current influence.

The timing of Bhattacharya’s comments is particularly noteworthy. He may soon be sidelined, as a procedural quirk in federal law dictates that if President Trump doesn’t nominate a permanent CDC director by the end of today, March 25, 2026, no one can serve in an acting capacity. Department of Health and Human Services spokesperson Andrew Nixon stated that Bhattacharya will continue to oversee the CDC by performing delegable duties until a nominee is found, but the future of his leadership remains uncertain.

A Series of Setbacks for Kennedy’s Agenda

This internal discord comes amidst a series of challenges for Kennedy and the MAHA movement. Recent setbacks include Trump’s signing of an executive order shielding glyphosate manufacturers from legal liability – a move that angered MAHA supporters, given Kennedy’s past opposition to the herbicide. The confirmation of Casey Means, Trump’s nominee for surgeon general and a Kennedy ally, appears stalled in the Senate. Vinay Prasad, the FDA’s vaccine chief and another prominent figure within the MAHA orbit, is set to leave his position at the end of April, following a turbulent tenure.

Perhaps most significantly, a federal judge recently ruled that the CDC’s January reduction of the childhood vaccine schedule was likely illegal, and implicated Kennedy in the decision-making process. The judge ordered that all decisions made by the CDC’s revamped vaccine advisory panel be put on hold. Robert Malone, the vice chair of that panel and a vocal proponent of the MAHA movement, resigned yesterday, according to reporting from the New York Times.

The Search for a Permanent Director: A Rocky Road

Finding a permanent CDC director has proven difficult. Trump’s first nominee, Dave Weldon, was withdrawn before his Senate confirmation hearing due to a lack of support. Susan Monarez, the second nominee, was approved by the Senate but subsequently removed by Kennedy, who reportedly asked her to dismiss public health experts and approve recommendations from the agency’s reconstituted vaccine advisory board. Monarez testified that she was fired because she refused to be “trustworthy” to Kennedy. Her ouster triggered a wave of resignations from top CDC officials, including Debra Houry, the agency’s chief medical officer, who cited a lack of “scientific leadership.”

The current situation – with Bhattacharya serving as acting director while simultaneously leading the National Institutes of Health (overseeing roughly 30,000 people across agencies 650 miles apart) – is clearly unsustainable. While Bhattacharya has been described by some CDC researchers as a welcome return to reason, he also carries his own baggage, having faced criticism for his contrarian views on the pandemic, as reported by The Atlantic.

Beyond Vaccines: A Broader Retreat?

The White House appears to be reining in Kennedy’s more ambitious public health initiatives. A December poll, conducted by Republican strategists Tony Fabrizio and Bob Ward, revealed potential “electoral downsides” for candidates supporting a rollback of vaccine recommendations. The Washington Post reported that the White House subsequently pressured HHS to halt further vaccine policy changes and installed Chris Klomp as a new chief counselor to oversee the department.

This shift is reflected in Kennedy’s recent public appearances. He has largely retreated from discussing vaccine issues, instead focusing on his “inverted food pyramid” and issuing vague threats to companies selling processed snacks. A recent event in Austin saw Kennedy promising to demand proof of safety from Dunkin’ and Starbucks for their high-sugar drinks, followed by an AI-generated video of Kennedy body-slamming a man in a Twinkie costume posted by HHS.

What’s on the Horizon for the CDC?

The nomination of a new CDC director with mainstream public health credentials could signal a return to normalcy. Potential candidates include Joseph Marine, who has defended Kennedy and supported the MAHA movement, and Daniel Edney, Mississippi’s state health officer, a proponent of childhood vaccination. Whoever is confirmed will inherit an agency in necessitate of significant trust-building. During today’s meeting, a CDC employee asked Bhattacharya how he planned to rebuild that trust, prompting nearly 30 seconds of applause. Bhattacharya responded that the agency should “deescalate scientific disagreement.”

The long-term impact of Kennedy’s tenure at HHS remains to be seen, but the recent setbacks suggest his influence is waning. The agency’s future direction will depend heavily on the next director’s priorities and their ability to navigate the complex political landscape.